Finding the best heart rate target for atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests whether a target heart rate (below 80 beats per minute) is better than a more lenient one for people with persistent or permanent atrial fibrillation. It aims to find the best way to control your heart rate and improve your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have persistent or permanent atrial fibrillation (AF lasting more than 7 days or over 1 year without plan to restore normal rhythm).
- Your resting heart rate is 80 beats per minute or higher on an ECG.
- You and your doctor agree to manage your AF by controlling your heart rate.
- You do not have a serious heart block or other condition that makes lowering your heart rate unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different ablation techniques to treat a type of irregular heartbeat that doesn't go away on its own. It aims to find which approach works better and is safer.
This study compares different treatments—pacing therapy, medications, and catheter ablation—for people who have both atrial fibrillation and heart failure. It aims to find the best way to improve your heart function and quality of life.
This trial compares two ways to treat atrial fibrillation in people with heart failure where the heart's pumping strength is still normal. You'll either get a procedure called ablation to restore normal rhythm or medication to control your heart rate. The goal is to see which approach works better for people like you.
This study investigates whether a catheter ablation procedure can improve wellbeing and reduce the risk of serious events for people 80 and older with symptomatic atrial fibrillation. The goal is to see if this treatment offers better outcomes than standard care in this age group.
This trial tests whether starting treatment early to control your heart's rhythm can help people with a heart device who have short bursts of a fast heartbeat (called atrial high rate episodes) but haven't yet been diagnosed with atrial fibrillation on a standard EKG or Holter monitor.
This trial is testing whether giving amiodarone (a heart-rhythm medicine) before an electrical cardioversion can help restore normal heart rhythm better in people with persistent atrial fibrillation. The goal is to see if the medicine makes the procedure more likely to succeed and reduces the chance of the irregular rhythm returning.
Hear when a new Atrial Fibrillation (Permanent) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.